The huge growth of prescription GLP-1 medications has produced a parallel wave of supplements marketed as natural, over-the-counter alternatives — sold with language deliberately echoing GLP-1 drug branding. This is one trend worth approaching with real skepticism rather than excitement.
The U.S. Federal Trade Commission has published specific reference guidance for media and advertisers on weight-loss claims precisely because this category has a long, documented history of exaggerated and unsubstantiated marketing. No dietary supplement ingredient has been shown in rigorous, large-scale clinical trials to replicate the weight-loss results of prescription GLP-1 receptor agonists — the mechanisms are simply not comparable, regardless of how a product is branded.
That doesn’t mean every ingredient marketed this way (berberine, certain fiber blends, chromium, and others) is worthless — some have real, modest research behind specific outcomes like blood sugar management, covered on their own terms elsewhere on this blog. It does mean any product explicitly positioned as an alternative to a prescription medication deserves a higher bar of evidence before you spend money on the promise, not just the branding.
Official source: U.S. Federal Trade Commission — Weight-Loss Advertising Enforcement Guidance
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.